| FSSNX | WSCJX | FSSNX / WSCJX | |
| Total Expense Ratio | 0.03 | 0.50 | 5% |
| Annual Report Gross Expense Ratio | 0.03 | 0.86 | 3% |
| Fund Existence | 14 years | 9 years | - |
| Gain YTD | 11.561 | 17.112 | 68% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 29B | 117M | 24,786% |
| Annual Yield % from dividends | 0.80 | 0.40 | 202% |
| Returns for 1 year | 4.32 | 4.37 | 99% |
| Returns for 3 years | 36.90 | 39.76 | 93% |
| Returns for 5 years | 47.37 | 66.94 | 71% |
| Returns for 10 years | 111.26 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JNGLX | 81.36 | 0.73 | +0.91% |
| Janus Henderson Global Life Sciences D | |||
| ACVRX | 11.43 | 0.10 | +0.88% |
| American Century International Val R | |||
| TBWIX | 22.57 | 0.18 | +0.80% |
| Thornburg Better World International I | |||
| PUMYX | 15.04 | N/A | N/A |
| PACE Small/Medium Co Growth Equity Y | |||
| ABCEX | 10.29 | N/A | N/A |
| AB Emerging Markets Multi-Asset C | |||